Literature DB >> 700890

Inhibition by lymphoblastoid interferon of growth of cells derived from the human breast.

F Balkwill, D Watling, J Taylor-Papadimitriou.   

Abstract

Human lymphoblastoid interferon inhibited the growth in vitro of fibroblasts and epithelial cells from normal, hyperplastic and neoplastic human breast tissue. At an interferon concentration of 10(3) inter-national units (IU) per ml, the inhibitory effects on monolayer growth were completely reversible but the growth potential of cells at lower density in colony-forming cultures was not completely recovered. Studies on the cell cycle distribution of interferon-treated cells demonstrated that the growth-inhibitory effect was not due to an effect on one specific phase of the cell cycle, but to a lengthening of all phases.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 700890     DOI: 10.1002/ijc.2910220307

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

Review 1.  Biological response modifiers in the management of patients with breast cancer.

Authors:  D L Longo; L C Hartmann
Journal:  Breast Cancer Res Treat       Date:  1990-09       Impact factor: 4.872

Review 2.  Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications.

Authors:  Martina Musella; Gwenola Manic; Ruggero De Maria; Ilio Vitale; Antonella Sistigu
Journal:  Oncoimmunology       Date:  2017-04-05       Impact factor: 8.110

Review 3.  Antitumour actions of interferons: implications for cancer therapy.

Authors:  Belinda S Parker; Jai Rautela; Paul J Hertzog
Journal:  Nat Rev Cancer       Date:  2016-03       Impact factor: 60.716

Review 4.  Regulation of cell proliferation and differentiation by interferons.

Authors:  M J Clemens; M A McNurlan
Journal:  Biochem J       Date:  1985-03-01       Impact factor: 3.857

Review 5.  Regulation of cell growth by interferon.

Authors:  M Shearer; J Taylor-Papadimitriou
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

6.  The effects of interferon on glial cells.

Authors:  M R Stratton; J M Martin; P L Lantos
Journal:  Br J Exp Pathol       Date:  1987-10

7.  A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer.

Authors:  Ning Cheng; Rebekah Watkins-Schulz; Robert D Junkins; Clément N David; Brandon M Johnson; Stephanie A Montgomery; Kevin J Peine; David B Darr; Hong Yuan; Karen P McKinnon; Qi Liu; Lei Miao; Leaf Huang; Eric M Bachelder; Kristy M Ainslie; Jenny P-Y Ting
Journal:  JCI Insight       Date:  2018-11-15

8.  Inhibition of cell division by interferons. The relationship between changes in utilization of thymidine for DNA synthesis and control of proliferation in Daudi cells.

Authors:  D R Gewert; G Moore; M J Clemens
Journal:  Biochem J       Date:  1983-09-15       Impact factor: 3.857

9.  Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cells.

Authors:  Evan R Abt; Thuc M Le; Amanda M Dann; Joseph R Capri; Soumya Poddar; Vincent Lok; Luyi Li; Keke Liang; Amanda L Creech; Khalid Rashid; Woosuk Kim; Nanping Wu; Jing Cui; Arthur Cho; Hailey Rose Lee; Ethan W Rosser; Jason M Link; Johannes Czernin; Ting-Ting Wu; Robert Damoiseaux; David W Dawson; Timothy R Donahue; Caius G Radu
Journal:  Cell Rep       Date:  2022-01-11       Impact factor: 9.423

10.  The MTT assay underestimates the growth inhibitory effects of interferons.

Authors:  S A Jabbar; P R Twentyman; J V Watson
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.